Bergenbio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, oral, selective...
Up to date
Appointments
Hox Therapeutics has announced the appointment of Dr Karl Keegan as Chief Executive Officer.
Oxurion NV (formerly known as ThromboGenics NV), a biopharmaceutical company developing treatments to preserve...
Zelluna Immunotherapy has announced the appointment of Geir Christian Melen as chief financial officer (CFO).
Aglaris Ltd. yesterday announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish...
Exscientia, a company in Artificial Intelligence (AI)-driven drug discovery, has announced the appointment of...
Share
